Smart clinical and diagnostic technologies

LBT Innovations specializes in advanced technologies for microbiology, particularly through its innovative APAS (Automated Plate Assessment System) technology. This system utilizes artificial intelligence to automate the imaging, analysis, and interpretation of agar culture plates, significantly enhancing the efficiency and accuracy of microbiological assessments. The APAS Independence, a key product, is recognized as the only scientifically validated instrument that employs AI to read environmental monitoring culture plates after incubation. This advancement not only improves the accuracy and traceability of results but also accelerates the plate triaging process, delivering reliable outcomes three times faster than traditional manual methods.

In addition to its core APAS technology, LBT Innovations focuses on developing a comprehensive AI platform that encompasses image capture, processing, and decision-making. The company employs a custom-designed, patented high-speed classification system for various image processing applications, which further enhances the capabilities of its microbiological solutions. By integrating intelligent imaging and AI, LBT Innovations is poised to disrupt conventional microbiology practices, offering pharmaceutical and clinical laboratories innovative tools that streamline workflows and improve diagnostic accuracy.

Australia

LBT Innovations is a medical technology company that utilizes artificial intelligence to deliver automation in healthcare through a patent-protected machine learning and intelligent imaging platform.

LBT Innovations

Company Details